Published in Br J Clin Pharmacol on January 01, 1983
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest (1988) 5.22
Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats. Br J Pharmacol (1984) 1.05
Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol (1994) 0.90
Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev (1978) 4.66
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
Pathogenesis of experimental shock. IV. Studies on lysosomes in normal and tolerant animals subjected to lethal trauma and endotoxemia. J Exp Med (1962) 2.39
Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med (1970) 2.21
Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest (1980) 1.91
Thromboxane synthetase inhibition as antithrombotic strategy. Lancet (1981) 1.82
Human serum beta-glucuronidase; its measurement and some of its properties. Clin Chim Acta (1967) 1.71
Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. Proc Natl Acad Sci U S A (1977) 1.56
Vasopressin stimulates thromboxane synthesis in the toad urinary bladder: effects of imidazole. J Pharmacol Exp Ther (1979) 1.35
Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. Am J Physiol (1981) 1.32
Regional localization of prostacyclin and thromboxane synthesis in dog stomach and intestinal tract. J Pharmacol Exp Ther (1979) 1.26
Pulmonary hypertension correlated to pulmonary thromboxane synthesis. Adv Prostaglandin Thromboxane Res (1980) 1.25
Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock. Circ Res (1980) 1.24
Mesenteric vascular responses to endotoxin in the monkey and dog. Am J Physiol (1970) 1.12
Pulmonary vascular response to endotoxin in intact dogs. Surgery (1973) 1.06
Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest (1981) 1.05
Blood levels of 6-oxo-prostaglandin F 1 alpha during endotoxin-induced hypotension in rabbits. Eur J Pharmacol (1980) 1.05
Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet (1981) 1.05
Relationship of TXB2 and 6-keto PGF1 alpha to the hemodynamic changes during baboon endotoxic shock. Adv Prostaglandin Thromboxane Res (1980) 1.03
Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther (1980) 1.03
Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ Shock (1978) 0.97
Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation. Thromb Res (1981) 0.96
Beneficial actions of imidazole in endotoxin shock. Prostaglandins Med (1980) 0.89
Essential fatty acid deficient rats: a new model for evaluating arachidonate metabolism in shock. Adv Shock Res (1981) 0.88
The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Circ Shock (1980) 0.87
Protective effects of aspirin in endotoxic shock. J Pharmacol Exp Ther (1981) 0.87
Thromboxane A2 and prostacyclin production by lipopolysaccharide-stimulated peritoneal macrophages. J Reticuloendothel Soc (1981) 0.87
Salutary effects of prostacyclin in endotoxic shock. Pharmacology (1980) 0.86
Blood levels of 6-keto-PGF1alpha, the stable metabolite of prostacyclin during endotoxin-induced hypotension. Arch Int Pharmacodyn Ther (1978) 0.85
64-Slice computed tomography angiography in the diagnosis and assessment of coronary artery disease: systematic review and meta-analysis. Heart (2008) 2.42
Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation (1995) 2.25
Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med (1995) 2.14
Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest (1980) 2.13
Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency. EMBO J (1990) 1.98
Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest (1980) 1.91
Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem Res Toxicol (1995) 1.90
Using concept mapping to develop a conceptual framework of staff's views of a supported employment program for individuals with severe mental illness. J Consult Clin Psychol (1994) 1.88
Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer (1993) 1.71
Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug. Clin Pharmacol Ther (2008) 1.50
The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys (1998) 1.49
Mediators of the secretory response to kinins. Br J Pharmacol (1984) 1.49
In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst (1994) 1.45
Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 1.40
A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands. Br J Cancer (1993) 1.39
Predicting death and readmission after intensive care discharge. Br J Anaesth (2008) 1.39
Rhabdomyolysis and a "greenhouse effect". Lancet (1990) 1.38
Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem (1997) 1.37
Vasopressin stimulates thromboxane synthesis in the toad urinary bladder: effects of imidazole. J Pharmacol Exp Ther (1979) 1.35
13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Proc Natl Acad Sci U S A (1979) 1.33
Phylogeography of lemmings (Lemmus): no evidence for postglacial colonization of Arctic from the Beringian refugium. Mol Ecol (2003) 1.31
Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer (1993) 1.30
Immune responses during human schistosomiasis mansoni. III. Regulatory effect of patient sera on human lymphocyte blastogenic responses to schistosome antigen preparations. Am J Trop Med Hyg (1977) 1.29
Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science (1978) 1.29
Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae. Int Arch Allergy Appl Immunol (1977) 1.28
In vivo imaging of a stable paramagnetic probe by pulsed-radiofrequency electron paramagnetic resonance spectroscopy. Magn Reson Med (1997) 1.26
The effects of alpha adrenergic agents on human platelet aggregation. J Pharmacol Exp Ther (1979) 1.26
Schistosome infections in humans: perspectives and recent findings. NIH conference. Ann Intern Med (1982) 1.25
Altered platelet function in diabetes mellitus. Diabetes (1976) 1.24
Phylogeography of the dusky shrew, Sorex monticolus (Insectivora, Soricidae): insight into deep and shallow history in northwestern North America. Mol Ecol (2001) 1.24
Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock. Circ Res (1980) 1.24
Phylogeography of a post-glacial colonizer: Microtus longicaudus (Rodentia: muridae). Mol Ecol (2000) 1.24
Parallel coil resonators for time-domain radiofrequency electron paramagnetic resonance imaging of biological objects. J Magn Reson (2000) 1.23
Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A (1998) 1.23
Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol (2001) 1.21
Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med (1981) 1.20
Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther (1985) 1.20
Isolation and characterization of a hantavirus from Lemmus sibiricus: evidence for host switch during hantavirus evolution. J Virol (1999) 1.20
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters. Diabetes (2001) 1.19
Holarctic phylogeography of the root vole (Microtus oeconomus): implications for late Quaternary biogeography of high latitudes. Mol Ecol (2003) 1.19
Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease. Infect Immun (1994) 1.14
Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide (1997) 1.11
Glucan-enhanced immunogenicity of killed erythrocyte stages of Plasmodium berghei. Infect Immun (1981) 1.11
Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Intensive Care Med (1986) 1.10
Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. N Engl J Med (1974) 1.10
High-speed data acquisition system and receiver configurations for time-domain radiofrequency electron paramagnetic resonance spectroscopy and imaging. J Magn Reson (1999) 1.09
Role of calcium ions in kinin-induced chloride secretion. Br J Pharmacol (1984) 1.08
Protective effect of glucan in experimentally induced candidiasis. J Reticuloendothel Soc (1978) 1.08
Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. J Leukoc Biol (2001) 1.07
Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol Lett (1995) 1.05
Cremophor EL, solvent for paclitaxel, and toxicity. Lancet (1993) 1.05
The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection. Arch Biochem Biophys (1996) 1.05
Prostaglandin-independent inhibition of calcium transport by nonsteroidal anti-inflammatory drugs: differential effects of carboxylic acids and piroxicam. J Pharmacol Exp Ther (1983) 1.04
Randomized controlled trial comparing rubber band ligation with stapled haemorrhoidopexy for Grade II circumferential haemorrhoids: long-term results. Colorectal Dis (2010) 1.04
Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther (1980) 1.03
Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol (1994) 1.02
A controlled study of morbidity of schistosomiasis mansoni in St. Lucian children, based on quantitative egg excretion. Am J Trop Med Hyg (1974) 1.02
Service delivery using consumer staff in a mobile crisis assessment program. Community Ment Health J (1996) 1.02
Resistance of essential fatty acid-deficient rats to endotoxic shock. Circ Shock (1979) 1.02
Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB. Head Neck (2000) 1.01
Biosynthesis of prostaglandin E by rat superior cervical ganglia. J Neurochem (1978) 1.01
Enhanced sensitivity to endotoxin induced by the RE stimulant, glucan. Circ Shock (1980) 1.00
Effect of pharmacist counseling on drug information recall. Am J Hosp Pharm (1982) 0.99
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther (1989) 0.99
Hydroxyurea reacts with heme proteins to generate nitric oxide. Lancet (1996) 0.99
Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann Intern Med (1977) 0.99
Lymphoma presenting to a head and neck clinic. Clin Otolaryngol Allied Sci (1995) 0.99
Kinin effects on chloride secretion do not require eicosanoid synthesis. Br J Pharmacol (1984) 0.99
Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther (1994) 0.99
Effect of stressor intensity on habituation of the adrenocortical stress response. Physiol Behav (1988) 0.98
Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis (1991) 0.98
Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Circulation (1985) 0.97
Influence of lead and cadmium on the susceptibility of rats to bacterial challenge. Proc Soc Exp Biol Med (1975) 0.97
The molecular phylogenetics of tuco-tucos (genus Ctenomys, Rodentia: Octodontidae) suggests an early burst of speciation. Mol Phylogenet Evol (1998) 0.97
Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. J Pharmacol Exp Ther (1985) 0.96
Clinical trial of hycanthone in Schistosomiasis mansoni in St. Lucia. Am J Trop Med Hyg (1971) 0.96
Microsatellite markers for American mink (Mustela vison) and ermine (Mustela erminea). Mol Ecol (1999) 0.96
Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation. Thromb Res (1981) 0.96
Endotoxin tolerance is associated with altered GTP-binding protein function. J Appl Physiol (1985) (1992) 0.96
Visceral leishmaniasis in mice: protective effect of glucan. J Reticuloendothel Soc (1980) 0.95
Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells. Oncol Res (1994) 0.95
Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines. Int J Oncol (1998) 0.95
Implications for thromboxane A2 in the pathogenesis of endotoxic shock. Adv Shock Res (1981) 0.95
Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol Med Microbiol (1994) 0.94